2018 Leibovich Model for Renal Cell Carcinoma (RCC)
Predicts progression-free and cancer-specific survival in patients with renal cell carcinoma (RCC).
Separate calculators are available for clear cell (ccRCC), papillary (papRCC), and chromophobe (chrRCC) histologies; always select the version that matches the surgical specimen.
Advice
- This tool should be used in conjunction with clinical expertise, specialist consultation, and patient preferences to direct treatment and monitoring.
- In general, risk estimates can guide:
- Surveillance intensity.
- Adjuvant therapy use, including immunotherapies.
- Prognosis counselling.
- Comorbidity management.
- Scores may also identify individuals who are appropriate for clinical trials.